Khaa H. Ong

Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: a marker of aggressive tumor behavior.

Prognostic impact of RPL15 overexpression in intrahepatic cholangiocarcinoma: a marker of aggressive tumor behavior.

Journal: Diagnostic pathology

Published: June 06, 2025

Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. Diagnostics 2023, 13, 2296.

Correction: Ong et al. Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker. Diagnostics 2023, 13, 2296.

Journal: Diagnostics (Basel, Switzerland)

Published: January 27, 2025

Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma.

Prognostic role of claudin-18.2 in intrahepatic cholangiocarcinoma.

Journal: Virchows Archiv : an international journal of pathology

Published: December 19, 2024

The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma.

The clinicopathological significance and prognostic impact of 14-3-3σ/stratifin expression on patients with surgically resectable intrahepatic cholangiocarcinoma.

Journal: Asian journal of surgery

Published: May 01, 2024

Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.

Underexpression of Carbamoyl Phosphate Synthetase I as Independent Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma: A Potential Theranostic Biomarker.

Journal: Diagnostics (Basel, Switzerland)

Published: May 25, 2023

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.

LAMC2 is a potential prognostic biomarker for cholangiocarcinoma.

Journal: Oncology letters

Published: April 28, 2023

Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.

Cartilage oligomeric matrix protein overexpression is an independent poor prognostic indicator in patients with intrahepatic cholangiocarcinoma.

Journal: Scientific reports

Published: February 10, 2023

Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.

Prognostic Significance of DNA Topoisomerase II Alpha (TOP2A) in Cholangiocarcinoma.

Journal: Frontiers in bioscience (Landmark edition)

Published: December 24, 2022

Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma.

Ubiquitin-conjugating enzyme E2C (UBE2C) is a prognostic indicator for cholangiocarcinoma.

Journal: European journal of medical research

Published: December 22, 2022

Association between Smoking and Overall and Specific Mortality in Patients with Bladder Cancer: A Population-based Study.

Association between Smoking and Overall and Specific Mortality in Patients with Bladder Cancer: A Population-based Study.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: July 13, 2021

Simultaneous Retroperitoneal Robotic Partial Nephrectomy and Hepatectomy for Synchronous Renal-Cell Carcinoma and Hepatocellular Carcinoma in a Cirrhotic Patient.

Simultaneous Retroperitoneal Robotic Partial Nephrectomy and Hepatectomy for Synchronous Renal-Cell Carcinoma and Hepatocellular Carcinoma in a Cirrhotic Patient.

Journal: Journal of endourology case reports

Published: November 22, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026